CardiacWire

AUGUST 18, 2024

The White House finally unveiled its negotiated Medicare drug prices , bringing 38%-76% reductions to the first 10 drugs, while drawing mixed industry reactions. Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time.

Medicare 59

Medicare CMS Drug Costs Diabetes 59

CardiacWire

MARCH 24, 2024

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.

Medicare 59

Medicare Obesity CMS Medicaid 59

Stroke Journal

JANUARY 30, 2025

We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Patients with diabetes (aOR, 95% CI: 2.99, 1.25-7.15) Model fit was assessed using the Hosmer-Lemeshow test.Results:Among 142 eligible pre-ICH statin users (median age [IQR]: 77.5 [72-86]

Medicare 40

Medicare CMS Medicaid Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Study Population includes all patients with an ischemic stroke inpatient admission in 2018 and were continuously enrolled with Medicare FFS for 1 year prior to and following their initial 2018 stroke admission. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient

Risk Factors 40

Risk Factors Stroke Strokes Medicare 40